U.S. Food and Drug Administration

Collage of images including drug vials with syringe, 3D rendering of coronavirus, and closeup of a person being administered a shot

Featured

FDA COVID-19 Response

FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

New Era of Smarter Food Safety

A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Science-related icons juxtoposed on a background of prescription paperwork

Fostering Drug Competition

Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Closeup shot of a nurse holding a patient's hand in comfort in a hospital

Combating the Opioid Crisis

FDA takes actions to combat prescription opioid abuse.

Oct 15

Coronavirus (COVID-19) Update: 10/15/21

Oct 14

FDA Awards 11 Grants to Clinical Trials to Develop New Medical Products for Rare Disease Treatments

More Press Announcements

Newsroom Meetings Testimony Speeches

Oct 14

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets Due to Potential Presence of N-nitrosoirbesartan Impurity

Drugs

Oct 12

Teligent Pharma, Inc.’s Issues Worldwide Voluntary Recall of Lidocaine HCl Topical Solution 4% Due to Super Potency

Drugs

Oct 11

Tuffy’s Pet Foods; Inc. Issues Voluntary Recall of a Limited Quantity of Pure Vita Salmon Entrée Dog Food in a Tetrapak Carton Due to Potentially Elevated Levels of Vitamin D

Animal & Veterinary

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List

Paragraph Header

Image depicting four medical devices. The devices include a Foley Catheter, Hemodialysis Room, Exam Table and Rack of Tubes.

How CDRH’s Digital Transformation Initiative Will Strengthen the Premarket Review Program

To meet our public health mission, it is critical that FDA continues to evolve to help speed innovations that make medical products safer and more effective.

Male in laboratory is looking at equipment and holding a black folder.

FDA’s Advanced Manufacturing Initiatives Helping to Provide Quality Human Drugs for Patients

FDA has established numerous initiatives, including the development of a research program to better understand the science of advanced manufacturing.

Image that depicts a DNA strand on the far left, and a variety of animals on the right side of the image.

Advancing the Development of Innovative Veterinary Products

FDA takes a proactive approach to provide timely and efficient review of innovative medical products for animals.

More FDA Voices

Oct 14

Select Updates for Unique Device Identification: Policy Regarding Global Unique Device Identification Database Requirements for Certain Devices

Biologics, Medical Devices

Oct 13